Dextromethorphan Hydrobromide; Guaifenesin; Naproxen Sodium Patent Expiration
Dextromethorphan Hydrobromide; Guaifenesin; Naproxen Sodium was first introduced by Rb Health Us Llc
Dextromethorphan Hydrobromide; Guaifenesin; Naproxen Sodium Patents
Given below is the list of patents protecting Dextromethorphan Hydrobromide; Guaifenesin; Naproxen Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Mucinex 12hr Cold & Fever Multi-symptom | US11278506 | Pharmaceutical Formulation | Oct 11, 2036 | Rb Hlth |
| Mucinex 12hr Cold & Fever Multi-symptom | US12257218 | Pharmaceutical Formulation | Oct 11, 2036 | Rb Hlth |
| Mucinex 12hr Cold & Fever Multi-symptom | US12370189 | Pharmaceutical Formulation | Oct 11, 2036 | Rb Hlth |
Dextromethorphan Hydrobromide; Guaifenesin; Naproxen Sodium's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List